JAMIE MOORE: Open Payments
NPI 1952962664 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,530 in 209 payments from 22 companies in 2025. Trend: 2023 $2,102 · 2024 $2,984 · 2025 $3,530
Food & beverage: $3,530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $452 |
| Janssen Pharmaceuticals, Inc | 37 | $413 |
| Otsuka America Pharmaceutical, Inc. | 19 | $391 |
| E.R. Squibb & Sons, L.L.C. | 21 | $338 |
| Teva Pharmaceuticals USA, Inc. | 18 | $306 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $305 |
| Corium, LLC | 12 | $257 |
| Neurocrine BioSciences, Inc. | 10 | $205 |
| Vanda Pharmaceuticals Inc. | 13 | $204 |
| Axsome Therapeutics, Inc. | 12 | $164 |
Products named: VRAYLAR, REXULTI, COBENFY, CAPLYTA, SPRAVATO, Azstarys, INGREZZA, FANAPT.
Industry payments across TX — which companies pay providers there.
